These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5615431)

  • 1. [Vasomotor effect of xanthinol niacinate].
    Warembourg H; Coget J; Merlen J
    Lille Med; 1967; 12(7):Suppl:753-4. PubMed ID: 5615431
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical trial of xanthinol nicotinate in delayed form in the treatment of arteritis of the lower limbs].
    Niquet G; Dupont T
    Lille Med; 1976 Jan; 21(1 suppl 1):13-5. PubMed ID: 1256225
    [No Abstract]   [Full Text] [Related]  

  • 3. [Critical evaluation of vasoactive and anticoagulant medication in stage II arteritis].
    Cristol R
    J Mal Vasc; 1980; 5(4):249-51. PubMed ID: 7240983
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical use of 53-14 C in the treatment of arteritis of the lower limbs].
    Warembourg H; Peltier JM
    Lille Med; 1971; 16(7):Suppl 3:917-21. PubMed ID: 5118954
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of a new vasodilator agent in medical indications of limb arteriopathies].
    Frieh P; Imbert D
    Lyon Med; 1970 Mar; 223(12):687-9. PubMed ID: 5438862
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical trial of Nicametate in vascular pathology].
    Langeron P
    J Sci Med Lille; 1972 Apr; 90(4):179-82. PubMed ID: 5079565
    [No Abstract]   [Full Text] [Related]  

  • 7. [Capillarographic control in vasodilator treatment of arteritis patients].
    Courbier R; Fouque R
    Therapeutique; 1969 Dec; 45(10):1031-2. PubMed ID: 5386100
    [No Abstract]   [Full Text] [Related]  

  • 8. [Trial of 4091 CB (benfurodil hemisuccinate) in the treatment of arteriopathies caused by atherosclerosis of lower limbs].
    Pierron J
    Mars Med; 1970; 107(5):445-6. PubMed ID: 5426012
    [No Abstract]   [Full Text] [Related]  

  • 9. [Action of a vasodilatator in arteriopathies. Study using double-blind method].
    Bouvrain Y; Roudy G; Martineaud JP
    Presse Med (1893); 1970 Apr; 78(21):977-8. PubMed ID: 4909924
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation in the arteritis patient, of the peripheral and cardiac effects of vasodilator agents by telethermography, thallium 201 scintigraphy and measurement of ejection fraction].
    Robert J; Thouvenot P; Laurens MH; Schmidt C; Schmitt J
    Sem Hop; 1981 Oct 18-25; 57(39-40):1613-7. PubMed ID: 6275512
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical trial of a delayed-action preparation of beta pyridyl-carbinol in vascular pathology].
    Warembourg H; Thery C
    Lille Med; 1970 Apr; 15(4 Suppl 3):599-602. PubMed ID: 5424406
    [No Abstract]   [Full Text] [Related]  

  • 12. [Medical treatment of arteritis of the lower limbs].
    Berkman M
    Therapeutique; 1971 Jan; 47(1):39-45. PubMed ID: 5572917
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of diabetic angiopathies].
    Fossati C
    Clin Ter; 1981 May; 97(4):419-26. PubMed ID: 7018823
    [No Abstract]   [Full Text] [Related]  

  • 14. [Value of a long-term vasodilatator therapeutic agent in chronic arteritis obliterans at the pre- or post-operative state].
    Lewintre M
    Mars Med; 1971; 108(7):557-63. PubMed ID: 5119500
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of chronic obliterating arteritis: importance of a combination of vasodilator products].
    LENG-LEVY J; DAVID-CHAUSSE J; SERRES A; LABORIE G; VEAUX R
    J Med Bord; 1957 Oct; 134(10):1218-24. PubMed ID: 13481517
    [No Abstract]   [Full Text] [Related]  

  • 16. [Determination of xanthinol nicotinate in drug preparations using capillary isotachophoresis].
    Pospísilová M; Jokl V; Dolejsová J
    Ceska Slov Farm; 2000 Mar; 49(2):88-90. PubMed ID: 10953450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombolytic and antiplatelet action of xanthinol nicotinate (Sadamin): possible mechanisms.
    Bieroń K; Swies J; Kostka-Trabka E; Gryglewski RJ
    J Physiol Pharmacol; 1998 Jun; 49(2):241-9. PubMed ID: 9670107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Complex treatment of unfavourable course of epilepsy in adolescents with anticonvulsants and complamin].
    Martyniuk VIu
    Vrach Delo; 1981 Oct; (10):95-7. PubMed ID: 7303594
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of "xanthinol niacinate" on platelet aggregation.
    Balkuv S; Akman N; Ulutin ON
    New Istanbul Contrib Clin Sci; 1967; 9(2):49-51. PubMed ID: 16300148
    [No Abstract]   [Full Text] [Related]  

  • 20. [Peripheral vasomotor drugs].
    BRUCKE F
    Wien Med Wochenschr; 1956 Nov; 106(45):931-2. PubMed ID: 13401751
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.